• JHU-083: 6-diazo-5-oxo-L-norleucine Precursor in Neuro-Redox

  2026-05-18

  JHU-083 stands out as a potent, selective glutaminase antagonist for precise manipulation of glutamate and glutathione pathways in experimental cerebral malaria and neurological disease models. This article details actionable workflows, advanced troubleshooting, and how JHU-083 enables reproducibility and pathophysiological relevance in glutamate excitotoxicity and redox biology research.

• Mitoxantrone HCl: Advanced DNA Topoisomerase II Inhibitor Wo

  2026-05-17

  Mitoxantrone HCl empowers researchers with dual-action capabilities—inducing DNA damage and uniquely disrupting estrogen receptor function. This guide delivers data-backed protocol enhancements, troubleshooting insights, and new avenues for resistance modeling, positioning APExBIO's Mitoxantrone HCl as an essential tool for high-impact cancer and immunology research.

• CDK4/6 and BET Inhibition Synergize via Wnt/β-Catenin Modula

  2026-05-16

  Gu et al. reveal that dual inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and reverses EMT by targeting the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight clarifies unexpected pro-metastatic effects of CDK4/6 inhibition and informs combinatorial therapeutic strategies.

• Dexamethasone: Glucocorticoid Anti-Inflammatory in Bench Wor

  2026-05-15

  Dexamethasone (DHAP) from APExBIO empowers precise, reproducible control of immune modulation and neuroinflammation in both cellular and animal models. Explore data-driven protocols, troubleshooting strategies, and comparative workflow advantages that unlock the full translational potential of this glucocorticoid anti-inflammatory.

• Pregnenolone-16α-carbonitrile Modulates Hippocampal CYP to P

  2026-05-15

  This study reveals that Pregnenolone-16α-carbonitrile selectively suppresses cytochrome P450 enzymes in the hippocampus via glucocorticoid receptor pathways, protecting against phenytoin-induced neurotoxicity in mice. The findings redefine the neuropharmacological roles of PCN and highlight distinct regulatory mechanisms compared to hepatic pathways, with implications for safer antiepileptic drug therapy.

• Biotin-16-UTP: Practical Guide for RNA Labeling and Detectio

  2026-05-14

  Biotin-16-UTP addresses the need for efficient, specific RNA labeling in workflows requiring RNA detection, purification, and interaction studies. It is best used in in vitro transcription protocols for generating biotinylated RNA, but is not intended for clinical or diagnostic applications. Researchers should follow storage and handling recommendations to maintain reagent integrity.

• Synthetic Viability with ERCC1 Deficiency in Lung Cancer Rep

  2026-05-14

  Heyza et al. demonstrate that ERCC1-deficient lung cancer cells exhibit synthetic viability in response to interstrand crosslinking agents, modulated by p53 status. These findings reshape the interpretation of ERCC1 as a platinum-based chemotherapy biomarker and underscore the interplay between DNA repair pathways and cell fate after genotoxic stress.

• Neurotensin: Precision Neurotensin Receptor 1 Activator for

  2026-05-13

  Neurotensin (CAS 39379-15-2) from APExBIO empowers researchers to dissect GPCR trafficking mechanisms and miRNA regulation in gastrointestinal models with unmatched specificity and purity. This article connects advanced fluorescence-based workflows with robust troubleshooting strategies, translating recent spectral interference breakthroughs into reproducible, high-impact experiments.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Mechanisms

  2026-05-13

  Diuron, a high-purity phenylurea herbicide, acts as a photosynthesis inhibitor and is increasingly studied for its nephrotoxic effects. Its mechanism involves photosystem II inhibition in plants and JAK2/STAT1 pathway activation in mammalian renal models. Recent network toxicology and experimental studies clarify its environmental and biological risks.

• Perphenazine: Bridging Dopamine Antagonism and Host-Directed

  2026-05-12

  Explore how Perphenazine, a dopamine D2 receptor antagonist, is shaping advanced neuropharmacology and host-pathogen research. This thought-leadership article integrates mechanistic insights, recent experimental evidence, and strategic guidance for translational researchers, highlighting new frontiers enabled by APExBIO’s Perphenazine (SKU B6157).

• iPSC Multilineage Organoids Enable Full Hepatitis E Virus Pr

  2026-05-12

  This study establishes induced pluripotent stem cell (iPSC)-derived multilineage liver, intestinal, and brain organoids as physiologically relevant models for hepatitis E virus (HEV) infection and replication. The platform advances virology research by supporting pan-genotype HEV propagation and elucidating tissue-specific pathogenic mechanisms, providing a robust alternative to existing in vitro and animal models.

• LDH Cytotoxicity Assay Kit in Advanced Nanocomposite Biocomp

  2026-05-11

  Explore how the LDH Cytotoxicity Assay Kit enables precise cell cytotoxicity measurement in cutting-edge nanocomposite research. This article uniquely connects quantitative assay selection to emerging insights from magnetic cellulose nanocrystal biocompatibility studies.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-05-11

  Wang et al. (2018) demonstrate that type III grass carp reovirus (GCRV104) enters kidney cells via clathrin-mediated, dynamin-dependent endocytosis, as revealed through systematic inhibitor studies. Their findings clarify the mechanistic basis of GCRV cellular entry, informing antiviral research and the strategic use of cytoskeletal inhibitors in related virological workflows.

• ABT-263 (Navitoclax): Redefining Apoptosis in Translational

  2026-05-10

  Explore the mechanistic depth and translational promise of ABT-263 (Navitoclax), a high-affinity Bcl-2 family inhibitor. This thought-leadership article integrates evidence from mitochondrial apoptosis research, strategic protocol guidance, and cross-study insights—empowering oncology researchers to design robust experiments and unlock new therapeutic paradigms.

• VX-745 in Precision Inflammation Research: Beyond Inhibition

  2026-05-09

  Explore how VX-745, a potent p38α MAPK inhibitor, enables precision modulation of inflammatory pathways. Discover new mechanistic insights and assay applications distinct from prior reviews.

454 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page